Women in cancer genetics vol II: 2022
Author: Giovana Tardin Torrezan
Publisher: Frontiers Media SA
Published: 2023-04-28
Total Pages: 156
ISBN-13: 2832522084
DOWNLOAD EBOOK →Author: Giovana Tardin Torrezan
Publisher: Frontiers Media SA
Published: 2023-04-28
Total Pages: 156
ISBN-13: 2832522084
DOWNLOAD EBOOK →Author: Cinzia Lanzi
Publisher: Frontiers Media SA
Published: 2023-07-26
Total Pages: 309
ISBN-13: 2832530591
DOWNLOAD EBOOK →Author: Sharon Prince
Publisher: Frontiers Media SA
Published: 2023-10-27
Total Pages: 206
ISBN-13: 2832525431
DOWNLOAD EBOOK →Author: Margaret Gatti-Mays
Publisher: Frontiers Media SA
Published: 2023-11-08
Total Pages: 217
ISBN-13: 2832538347
DOWNLOAD EBOOK →We are delighted to present the Frontiers in Oncology "Women in Breast Cancer” Volume II series of article collections. At present, less than 30% of researchers worldwide are women. Long-standing biases and gender stereotypes are discouraging girls and women away from science-related fields, and STEM research in particular. Science and gender equality are, however, essential to ensure sustainable development as highlighted by UNESCO. In order to change traditional mindsets, gender equality must be promoted, stereotypes defeated, and girls and women should be encouraged to pursue STEM careers.
Author: Kathy Steligo
Publisher: JHU Press
Published: 2022-09-27
Total Pages: 496
ISBN-13: 1421444259
DOWNLOAD EBOOK →"This book provides a comprehensive overview of hereditary cancer for a general audience, with coverage of the genetic tests available for detecting risk for heritable cancers as well as options for medical and surgical treatment"--
Author: B.A. Ponder
Publisher: Springer Science & Business Media
Published: 2012-12-06
Total Pages: 222
ISBN-13: 9401106770
DOWNLOAD EBOOK →It has been recognized for almost 200 years that certain families seem to inherit cancer. It is only in the past decade, however, that molecular genetics and epidemiology have combined to define the role of inheritance in cancer more clearly, and to identify some of the genes involved. The causative genes can be tracked through cancer-prone families via genetic linkage and positional cloning. Several of the genes discovered have subsequently been proved to play critical roles in normal growth and development. There are also implications for the families themselves in terms of genetic testing with its attendant dilemmas, if it is not clear that useful action will result. The chapters in The Genetics of Cancer illustrate what has already been achieved and take a critical look at the future directions of this research and its potential clinical applications.
Author: Yong-mi Kim
Publisher: Frontiers Media SA
Published: 2023-07-21
Total Pages: 164
ISBN-13: 2832529682
DOWNLOAD EBOOK →Author: Lida A. Mina
Publisher: Springer
Published: 2016-06-02
Total Pages: 104
ISBN-13: 3319194372
DOWNLOAD EBOOK →Uniquely designed for oncologists and general practitioners, this book offers clinicians comprehensive guidelines when dealing with women at high risk for breast cancer. Written by experts in the field on the cutting edge of this research, the following questions will be answered for the reader by the end of the book: · Who is at elevated risk for breast cancer? · Who should be genetically screened? · When and how often should we obtain imaging? · What type of imaging is adequate? · What medications are available for prevention? · When is surgical intervention appropriate? · What lifestyle changes should be implemented to prevent this disaster? With one in eight women likely to contract breast cancer in her lifetime, the significance of identifying and managing the high-risk patient is evident. Breakthroughs in the identification of genes associated with breast carcinoma, particularly BRCA1 and 2, as well as other risk factors, influence not only how patients are screened, but also how they are treated. Breast Cancer Prevention and Treatment provides a guided approach to prevention of breast cancer in women at elevated risk for this malignancy.
Author: Sapna Patel
Publisher: Frontiers Media SA
Published: 2023-09-06
Total Pages: 84
ISBN-13: 283253306X
DOWNLOAD EBOOK →Author: Robert Bazell
Publisher: Random House
Published: 2011-04-27
Total Pages: 241
ISBN-13: 0307764982
DOWNLOAD EBOOK →Two years after she underwent a mastectomy and chemotherapy, Barbara Bradfield's aggressive breast cancer had recurred and spread to her lungs. The outlook was grim. Then she took part in Genentech's clinical trials for a new drug. Five years later she remains cancer-free. Her-2 is the biography of Herceptin, the drug that provoked dramatic responses in Barbara Bradfield and other women in the trials and that offers promise for hundreds of thousands of breast cancer patients. Unlike chemotherapy or radiation, Herceptin has no disabling side effects. It works by inactivating Her-2/neu--a protein that makes cancer cells grow especially quickly-- produced by a gene found in 25 to 30 percent of all breast tumors. Herceptin caused some patients' cancers to disappear completely; in others, it slowed the progression of the disease and gave the women months or years they wouldn't otherwise have had. Herceptin is the first treatment targeted at a gene defect that gives rise to cancer. It marks the beginning of a new era of treatment for all kinds of cancers. Robert Bazell presents a riveting account of how Herceptin was born. Her-2 is a story of dramatic discoveries and strong personalities, showing the combination of scientific investigation, money, politics, ego, corporate decisions, patient activism, and luck involved in moving this groundbreaking drug from the lab to a patient's bedside. Bazell's deft portraits introduce us to the remarkable people instrumental in Herceptin's history, including Dr. Dennis Slamon, the driven UCLA oncologist who played the primary role in developing the treatment; Lily Tartikoff, wife of television executive Brandon Tartikoff, who tapped into Hollywood money and glamour to help fund Slamon's research; and Marti Nelson, who inspired the activists who lobbied for a "compassionate use" program that would allow women outside the clinical trials to have access to the limited supplies of Herceptin prior to FDA approval of the drug. And throughout there are the stories of the heroic women with advanced breast cancer who volunteered for the trials, risking what time they had left on an unproven treatment. Meticulously researched, written with clarity and compassion, Her-2 is masterly reporting on cutting-edge science.